More research is needed to understand the connections between HIV, mental health, and the neurocircuitry that controls executive function.
A pooled analysis presented at CROI 2019 showed fewer kidney and bone density issues with tenofovir alafenamide in cisgender women than were found with the older formulation.
A CROI 2019 study suggests the dynamics of HIV proliferation in the viral reservoir might explain why viral load sometimes fails to become undetectable, especially when adherence is good.
Paul Sax, M.D., provides highlights of the important and interesting studies that caught his eye at AIDS 2018.
There are a number of measures determine adherence to PrEP, each with benefits and drawbacks. Currently, no one guideline or definitive standard is being used.
Leading researchers and clinicians who influence best practices for conversations about the direct and indirect impact of HIV infection and treatment agree that communications regarding transmission must shift.
At the recent Adherence 2018 Conference, Friedland emphasized the importance of engaging providers, as well as expanding the definition of HIV providers beyond the clinical setting to include social workers, HIV test counselors, and lawyers.
A panel at the 13th annual International Conference on HIV Treatment and Prevention Adherence discussed the ways in which violence complicates health outcomes for people with HIV.
Providers and researchers at the Adherence 2018 Conference discussed the role of data and surveillance through several approaches and how they are being used to understand local and global epidemics, marshal resources, and mobilize stakeholders for i...
Gina Brown, M.D., shares her reflections on some of the many research findings about HIV prevention, care, and treatment for women and girls presented at CROI 2018.